tm
Seeing Is Believing
tm
Seeing Is Believing
CYCC is currently covered by 3 analysts with an average price target of $8.81. This is a potential upside of $7.14 (427.54%) from yesterday's end of day stock price of $1.67.
Cyclacel Pharmaceuticals's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of CYCC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 373.5 days.
Highest price target for CYCC is $16, Lowest price target is $8, average price target is $8.81.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 19-Dec-2023. First documented stock forecast 27-Apr-2020.
Currently out of the existing stock ratings of CYCC, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$13.89 (658.29%)
24
3 months 30 days ago
1/2 (50%)
$12.63 (374.78%)
742
Buy
8
$5.1 (175.86%)
10
10 months 24 days ago
3/3 (100%)
$-2.05 (-20.40%)
30
Buy
19
$16.89 (800.47%)
22
1 years 1 months 11 days ago
1/2 (50%)
$8.07 (73.83%)
722
Buy
17
1 years 9 months ago
0/1 (0%)
$9.89 (139.10%)
What is CYCC (Cyclacel Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most bullish on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most reserved on CYCC (Cyclacel Pharmaceuticals)?
